Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon

AIDS Research and Human Retroviruses

Volumn 18, Issue 15, 2002, Pages 1103-1116

  Pandrea, Ivona ^a,b   Apetrei, Cristian ^a,b   Robertson, David L ^c   Onanga, Richard ^a   Gao, Feng ^d   Makuwa, Maria ^a   Ngari, Paul ^a   Bedjabaga, Issa ^a   Roques, Pierre ^a   Simon, François ^a,e  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA FRAGMENT; LOPINAVIR; NEVIRAPINE; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS ENZYME; ZIDOVUDINE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; GABON; GENE AMPLIFICATION; GENE CLUSTER; GENE SEQUENCE; GENETIC RECOMBINATION; GENOTYPE; HETERODUPLEX ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; STRAIN DIFFERENCE; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS RESISTANCE; VIRUS STRAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; DRUG RESISTANCE, VIRAL; GABON; GENES, ENV; GENES, POL; HETERODUPLEX ANALYSIS; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 0036403169     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202320567842     Document Type: Article

References (53)

1. Kuiken C, Foley B, Hahn B, et al. (eds.): Human Retroviruses and AIDS 1999: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1999. [URL: http://hiv-web.lanl.gov]
2. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal: A reference guide to HIV-1 classification. In: Human Retroviruses and AIDS 1999: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequence. (Kuiken C, Foley B, Hahn B, et al., eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, 1999, pp. 492-505. [URL: http://hiv-web.lanl.gov]
3. Salminen MO, Carr JK, Robertson DL, et al.: Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol 1997;71:2647-2655.
4. Vidal N, Peeters M, Mulanga-Kabeya C, et al.: Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000;74:10498-10507.
5. Tscherning-Casper C, Dolcini G, Mauclère P, et al.: Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. AIDS Res Hum Retroviruses 2000;16:1313-1318.
6. Novitsky VA, Gaolekwe S, McLane MF, et al.: HIV type 1 A/J recombinant with a pronounced pol gene mosaicism. AIDS Res Hum Retroviruses 2000;16:1015-1020.
7. Gao F, Robertson DL, Carruthers CD, et al.: An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G and I). J Virol 1998;72:10234-10241.
8. Choi DJ, Dube S, Spicer TP, Slade HB, Jensen FC, and Poiesz BJ: HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant. AIDS Res Hum Retroviruses 1997;13:357-361.
9. Loussert-Ajaka I, Ly TD, Chaix ML, et al.: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-1394.
10. Apetrei C, Loussert-Ajaka I, Descamps D, et al.: Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS 1996;10:F57-F60.
11. Corrigan GE, Al-Khalili L, Malmsten A, et al.: Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains. AIDS Res Hum Retroviruses 1998;14:347-352.
12. Arnold C, Barlow KL, Kaye S, Loveday C, Balfe P, and Clewley JP: HIV type 1 sequence subtype G transmission from mother to infant: Failure of variant sequence species to amplify in the Roche Amplicor test. AIDS Res Hum Retroviruses 1995;11:999-1001.
13. Damond F, Apetrei C, Descamps D, Brun-Vézinet F, and Simon F: HIV-1 subtypes and plasma RNA quantification. AIDS 1999;13:286-288.
14. Descamps D, Collin G, Letourneur F, et al.: Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. J Virol 1997;71:8893-8898.
15. Apetrei C, Descamps D, Collin G, et al.: Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol 1998;72:3534-3538.
16. Descamps D, Apetrei C, Collin G, Damond F, Simon F, and Brun-Vézinet F: Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS 1998;12:1109-1111.
17. Soto-Ramirez LE, Renjifo B, McLane MF, et al.: HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-1293.
18. Dittmar MT, Simmonds G, Hibbitts S, et al.: Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J Virol 1997;71:8008-8013.
19. Tscherning C, Alaeus A, Fredriksson R, et al.: Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-188.
20. Kalish ML, Lou C-C, Weniger BG, et al.: Early HIV type 1 strains in Thailand were not responsible for the current epidemic AIDS Res Hum Retroviruses 1994;10:1573-1575.
21. Zolla-Pazner S, Gomy MK, and Nyambi PN: The implications of antigenic diversity for vaccine development. Immunol Lett 1999;66:159-164.
22. Peeters M and Sharp PM: Genetic diversity of HIV-1: The moving target. AIDS 2000;14(Suppl 3):S129-S140.
23. Delwart E, Sphaer E, Louwagie J, et al.: Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993;262:1257-1261.
24. Peeters M, Liegeois F, Bibollet-Ruche F, et al.: Subtype-specific polymerase chain reaction for the identification of HIV-1 genetic subtypes circulating in Africa. AIDS 1998;12:671-673.
25. Yahi N, Fantini J, Tourres C, Tivoli N, Koch N, and Tamalet C: Use of drug resistance sequence data for the systemic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. J Infect Dis 2001;183:1311-1317.
26. Hirsch MS, Brun-Vézinet F, D'Aquila RT, et al.: Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel. JAMA 2000;283:2417-2426.
27. Jetzt AE, Yu H, Karmann GJ, Ron Y, Preston BD, and Dougherty JP: High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 2000;74:1234-1240.
28. Delaporte E, Janssens W, Peeters M, et al.: Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS 1996;10:903-910.
29. Makuwa M, Souquière S, Apetrei C, Tevi-Benissan C, Bedjabaga I, and Simon F: HIV prevalence and strain diversity in Gabon: The end of a paradox. AIDS 2000;14:1275-1276.
30. Montavon C, Toure-Kane C, Liegeois F, et al.: Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IbNG. J Acquire Immune Defic Syndr 2000;23:363-374.
31. Nijhuis M, Boucher CAB, Schipper P, Leitner T, Schuurman R, and Albert J: Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc Natl Acad Sci USA 1998;95:14441-14446.
32. Nijhuis M, Boucher CAB, and Schuurman R: Sensitive procedure for the amplification of HIV-1 RNA using combined reverse-transcription and amplification reaction. BioTechniques 1995;19:178-182.
33. Gao F, Yue L, Robertson DL, et al.: Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994;68:7433-7347.
34. Heyndrickx L, Janssens W, Zekeng L, et al.: Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities. J Virol 2000;74:363-370.
35. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
36. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1985;4:406-425.
37. Hasegawa M, Kishino H, and Yano T: Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985;22:160-174.
38. Swofford D: PAUP*: Phylogenetic Analysis Using Parsimony (and Other Methods), version 4. Sinauer Associates, Sunderland, Massachusetts, 1999.
39. Peeters M: Recombinant HIV sequences: Their role in the global pandemic. In: Human Retroviruses and AIDS 2000: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Kuiken CL, Foley B, Hahn B, et al. eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 2000, pp. I39-I54.
40. Kempf DJ, Isaacson JD, King M, et al.: Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. J Virol 2001;75:7462-7469.
41. Peeters M, Esu-Williams E, Vergne L, et al.: Predominance of A and G human immunodeficiency viruses type 1 in Nigeria with geographical differences in their distribution. AIDS Res Hum Retroviruses 2000;16:315-325.
42. Cornelissen M, van den Burg R, Zorgdrager F, and Goudsmit J: Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J Gen Virol 2000;81:515-523.
43. Jonassen TO, Grinde B, Åsjö B, Hasle G, and Hungnes O: Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. AIDS Res Hum Retroviruses 2000;16:49-58.
44. Alizon M, Wain-Hobson S, Montagnier L, and Sonigo P: Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients. Cell 1986;46:63-74.
45. Vidal N, Mulanga-Kabeya C, Nzilambi N, Delaporte E, and Peeters M: Identification of a complex env subtype E HIV type 1 virus from the Democratic Republic of Congo, recombinant with A, G, H, J, K and unknown subtypes. AIDS Res Hum Retroviruses 2000;18:2059-2064.
46. Rambaut A, Robertson DL, Phybus OG, Peeters M, and Holmes EC: Phylogeny and the origin of HIV-1. Nature 2001;410:1047-1048.
47. Toure-Kane C, Montavon C, Faye MA, et al.: Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence. AIDS Res Hum Retroviruses 2000;16:603-609.
48. Loussert-Ajaka I, Menu E, Apetrei C, et al.: HIV type 1 diversity and the reliability of the heteroduplex mobility assays. AIDS Res Hum Retroviruses 1998;14:877-883.
49. Janssens W, Laukkanen T, Salminen MO, et al.: HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants. AIDS 2000;14:1533-1543.
50. Mboudjeka I, Bikandou B, Zekeng L, et al.: Genetic diversity of HIV-1 group M from Cameroon and Republic of Congo. Arch Virol 1999;144:2291-2311.
51. Pasquier C, Millot N, Njouom R, et al.: HIV subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001;94:45-54.
52. Pieniazek D, Rayfield M, Hu DJ, et al.: Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitornaïve individuals worldwide. AIDS 2000;14:1489-1495.
53. Pandrea I, Descamps D, Collin G, et al.: HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova. AIDs Res Hum Retroviruses 2001;17:1303-1310.